[ORGANIZATION]
Capricor Therapeutics
Featured in 5 tracked stories · first seen
Situations
Duchenne muscular dystrophy treatment developments
2 clusters · 5 sources · last updated
Latest: Duchenne muscular dystrophy advocates highlight treatment delays in Spain
The landscape for Duchenne muscular dystrophy (DMD) treatments is experiencing both clinical advancements and significant administrative hurdles. On the clinical front, therapeutic approaches are diversifying. Capricor
Deramiocel trial, FDA pivot, and ongoing lawsuit
5 clusters · 21 sources · last updated
Latest: Capricor Therapeutics pivots regulatory strategy amid legal challenges
Capricor Therapeutics is navigating a shifting regulatory and strategic landscape following an FDA advisory committee vote against the original effectiveness case for deramiocel in treating Duchenne cardiomyopathy. In re